Shawn W. Robinson, MD

AB, Biochemistry, Brown University

MD, University of Maryland School of Medicine 

Internship & Residency, Internal Medicine, University of Maryland Medical Center

Fellowship, Cardiovascular Medicine, The Johns Hopkins University Hospital

Dr. Robinson's clinical and research focus is congestive heart failure. He has over 15 years of experience serving as principal investigator or co-investigator on several acute and chronic heart failure clinical trials.  Additional research efforts include exploring how various genetic polymorphisms may influence cardiac function, treatment and response to medical therapy.  Clinically, Dr. Robinson attends heart failure and cardiomyopathy specialty practices at both the University of Maryland Medical System and The VA Maryland Health Care System.  

Heart failure, Cardiomyopathy, Pharmacogenomics

Parsa A, Chang YP, Kelly RJ, Corretti MC, Ryan KA, Robinson SW, Gottlieb SS, Kardia SL, Shuldiner AR, Liggett SB.  Hypertrophy-associated polymorphisms ascertained in a founder cohort applied to heart failure risk and mortality.Clin Transl Sci. 2011 Feb;4(1):17-23

Shuldiner AR, Relling MV, Peterson JF, Hicks JK, Freimuth RR, Sadee W, Pereira NL, Roden DM, Johnson JA, Klein TE; Pharmacogenomics Research Network Translational Pharmacogenetics Program Group, Shuldiner AR, Vesely M, Robinson SW, et.al. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther. 2013 Aug;94(2):207-10. doi: 10.1038/clpt.2013.59. Epub 2013 Mar 19. PMID: 23588301 

Shuldiner AR, Palmer K, Pakyz RE, Alestock TD, Maloney KA, O'Neill C, Bhatty S, Schub J, Overby CL, Horenstein RB, Pollin TI, Kelemen MD, Beitelshees AL, Robinson SW, Blitzer MG, McArdle PF, Brown L, Jeng LJB, Zhao RY, Ambulos N, Vesely MR. 2014. Implementation of pharmacogenetics: The University of Maryland personalized anti‐platelet pharmacogenetics program. Am J Med Genet Part C 166C:76–84

Vesely MR, Benitez RM, Robinson SW, Collins JA, Dawood MY, Gammie JS.  Surgical and Transcatheter Mitral Valve Repair for Severe Chronic Mitral Regurgitation: A Review of Clinical Indications and Patient Assessment.  J Am Heart Assoc. 2015 Dec 11;4(12).

Rogers HL, Marshall J, Bock J, Dowling TC, Feller E, Robinson S, Gottlieb SS. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. J Card Fail. 2008 Feb;14(1):1-5.